GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Market Cap : ₦20,330 Mil (As of Jun. 10, 2024)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). GlaxoSmithKline Consumer Nigeria's share price for the quarter that ended in Jun. 2023 was ₦7.4. GlaxoSmithKline Consumer Nigeria's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 1,196 Mil. Therefore, GlaxoSmithKline Consumer Nigeria's market cap for the quarter that ended in Jun. 2023 was ₦8,850 Mil.

GlaxoSmithKline Consumer Nigeria's quarterly market cap increased from Sep. 2022 (₦6,697 Mil) to Dec. 2022 (₦7,355 Mil) and increased from Dec. 2022 (₦7,355 Mil) to Jun. 2023 (₦8,850 Mil).

GlaxoSmithKline Consumer Nigeria's annual market cap declined from Dec. 2020 (₦8,252 Mil) to Dec. 2021 (₦7,115 Mil) but then increased from Dec. 2021 (₦7,115 Mil) to Dec. 2022 (₦7,355 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. GlaxoSmithKline Consumer Nigeria's Enterprise Value for Today is ₦2,329 Mil.

GlaxoSmithKline Consumer Nigeria Market Cap Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Market Cap Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

17,340.26

7,294.87

8,251.57

7,115.49

7,354.66

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Market Cap	Get a 7-Day Free Trial															6,816.52	7,773.22	6,696.93	7,354.66	8,849.51

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Market Cap

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Market Cap distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Market Cap falls into.

GlaxoSmithKline Consumer Nigeria Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

GlaxoSmithKline Consumer Nigeria's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	₦6.15	*	1195.88
	=	₦7,355

GlaxoSmithKline Consumer Nigeria's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	₦7.4	*	1195.88
	=	₦8,850

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

GlaxoSmithKline Consumer Nigeria Market Cap Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines